A 10 Day Schedule of Azacitidine Induces More Complete Cytogenetic Remissions Than the Standard Schedule In Myelodysplasia and Acute Myeloid Leukemia with Myelodysplasia-Related Changes: Results of the E1905 US Leukemia Intergroup Study
Publication
, Conference
Prebet, T; Sun, Z; Ketterling, R; Hicks, G; Beach, CL; Greenberg, PL; Paietta, E; Czader, M; Gabrilove, J; Erba, HP; Tallman, MS; Gore, SD
Published in: BLOOD
November 19, 2010
Duke Scholars
Published In
BLOOD
ISSN
0006-4971
Publication Date
November 19, 2010
Volume
116
Issue
21
Start / End Page
1636 / 1636
Location
Orlando, FL
Publisher
AMER SOC HEMATOLOGY
Conference Name
52nd Annual Meeting of the American-Society-of-Hematology (ASH)
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Prebet, T., Sun, Z., Ketterling, R., Hicks, G., Beach, C. L., Greenberg, P. L., … Gore, S. D. (2010). A 10 Day Schedule of Azacitidine Induces More Complete Cytogenetic Remissions Than the Standard Schedule In Myelodysplasia and Acute Myeloid Leukemia with Myelodysplasia-Related Changes: Results of the E1905 US Leukemia Intergroup Study. In BLOOD (Vol. 116, pp. 1636–1636). Orlando, FL: AMER SOC HEMATOLOGY.
Prebet, Thomas, Zhuoxin Sun, Rhett Ketterling, Gary Hicks, C. L. Beach, Peter L. Greenberg, Elisabeth Paietta, et al. “A 10 Day Schedule of Azacitidine Induces More Complete Cytogenetic Remissions Than the Standard Schedule In Myelodysplasia and Acute Myeloid Leukemia with Myelodysplasia-Related Changes: Results of the E1905 US Leukemia Intergroup Study.” In BLOOD, 116:1636–1636. AMER SOC HEMATOLOGY, 2010.
Prebet T, Sun Z, Ketterling R, Hicks G, Beach CL, Greenberg PL, et al. A 10 Day Schedule of Azacitidine Induces More Complete Cytogenetic Remissions Than the Standard Schedule In Myelodysplasia and Acute Myeloid Leukemia with Myelodysplasia-Related Changes: Results of the E1905 US Leukemia Intergroup Study. In: BLOOD. AMER SOC HEMATOLOGY; 2010. p. 1636–1636.
Prebet, Thomas, et al. “A 10 Day Schedule of Azacitidine Induces More Complete Cytogenetic Remissions Than the Standard Schedule In Myelodysplasia and Acute Myeloid Leukemia with Myelodysplasia-Related Changes: Results of the E1905 US Leukemia Intergroup Study.” BLOOD, vol. 116, no. 21, AMER SOC HEMATOLOGY, 2010, pp. 1636–1636.
Prebet T, Sun Z, Ketterling R, Hicks G, Beach CL, Greenberg PL, Paietta E, Czader M, Gabrilove J, Erba HP, Tallman MS, Gore SD. A 10 Day Schedule of Azacitidine Induces More Complete Cytogenetic Remissions Than the Standard Schedule In Myelodysplasia and Acute Myeloid Leukemia with Myelodysplasia-Related Changes: Results of the E1905 US Leukemia Intergroup Study. BLOOD. AMER SOC HEMATOLOGY; 2010. p. 1636–1636.
Published In
BLOOD
ISSN
0006-4971
Publication Date
November 19, 2010
Volume
116
Issue
21
Start / End Page
1636 / 1636
Location
Orlando, FL
Publisher
AMER SOC HEMATOLOGY
Conference Name
52nd Annual Meeting of the American-Society-of-Hematology (ASH)
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology